Table 2.

Causality assessment evaluating if the use of corticosteroids in COVID-19 patients determined the acute strongyloidiasis manifestations.

Study	Certain	Probable/Likely	Possible	Unlikely	Conditional/Unclassified	Unassessable/Unclassifiable
Alian 2022 [25]	No	No	No	No	No	Yes
Babazadeh 2022 [26]	No	Yes	No	No	No	No
Feria 2022 case 1 [27]	No	Yes	No	No	No	No
Feria 2022 case 2 [27]	No	Yes	No	No	No	No
Gautam 2021 [28]	No	No	Yes	No	No	No
Kim 2022 [29]	No	Yes	No	No	No	No
Lier 2022 [30]	Yes	No	No	No	No	No
Lorenzo 2022 patient 1 [31]	No	No	No	No	No	Yes
Lorenzo 2022 patient 2 [31]	No	No	No	No	No	Yes
Lorenzo 2022 patient 3 [31]	No	No	No	No	No	Yes
Lorenzo 2022 patient 4 [31]	No	No	No	No	No	Yes
Lorenzo 2022 patient 5 [31]	No	No	No	No	No	Yes
Lorenzo 2022 patient 6 [31]	No	No	No	No	No	Yes
Lorenzo 2022 patient 7 [31]	No	No	No	No	No	Yes
Marchese 2021 [32]	No	No	Yes	No	No	No
Martinez 2021 [33]	No	No	No	No	No	Yes
Nakandakaria 2021 [34]	No	No	No	Yes	No	No
Nunez-Gomez 2021 [35]	No	No	Yes	No	No	No
O’Dowling 2022 [36]	No	No	No	Yes	No	No
Patel 2021 [37]	No	No	Yes	No	No	No
Pintos-Pascual 2021 [38]	No	Yes	No	No	No	No
Singh 2021 [39]	No	No	No	No	No	Yes
Stylemans 2021 [40]	No	No	Yes	No	No	No